FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 355:2670-2676 December 21, 2006 Number 25 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text PowerPoint Slide Set Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

The term "autoimmune pancreatitis" (or "autoimmune-related pancreatitis") was introduced by Yoshida et al. in 1995 to describe the form of chronic pancreatitis that is associated with autoimmune manifestations revealed on laboratory, histologic, and clinical testing.¹ In the past 10 years, interest in autoimmune pancreatitis has grown because of an increasing ability to diagnose it with the use of new markers of disease and pancreatic biopsy. Treatment of autoimmune pancreatitis with corticosteroids leads to the rapid and sustained resolution of pancreatic mass lesions, biliary obstruction, and pancreatic-duct strictures, which has stimulated widespread interest in this condition from gastroenterologists, endoscopists, pathologists, and . . . [Full Text of this Article]

Definition

Epidemiology

Cause and Pathogenesis

Pathology

Clinical Features

Diagnostic Imaging

Diagnostic Criteria

Diagnostic and Therapeutic Approaches

Source Information

From the Departments of Medicine (Gastrointestinal Unit) (D.L.F., W.R.B.), Radiology (D.S.), and Pathology (V.D.), Massachusetts General Hospital, Boston.

Address reprint requests to Dr. Brugge at the Gastrointestinal Unit, Blake 452c, Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114, or at wbrugge@partners.org.

Related Letters:

Autoimmune Pancreatitis
Ralli S., Lin J., Farrell J., Leclercq P., Meurisse N., Honore P., Raina A., Yadav D., Krasinskas A. M., Brugge W. R.
Extract | Full Text | PDF  
N Engl J Med 2007; 356:1586-1587, Apr 12, 2007. Correspondence

This article has been cited by other articles:

• Chen, T S, Montgomery, E A (2008). Are tumefactive lesions classified as sclerosing mesenteritis a subset of IgG4-related sclerosing disorders?. J. Clin. Pathol. 61: 1093-1097 [Abstract] [Full Text]  
• Menias, C. O., Surabhi, V. R., Prasad, S. R., Wang, H. L., Narra, V. R., Chintapalli, K. N. (2008). Mimics of Cholangiocarcinoma: Spectrum of Disease. RadioGraphics 28: 1115-1129 [Abstract] [Full Text]  
• Meagher, C., Tang, Q., Fife, B. T., Bour-Jordan, H., Wu, J., Pardoux, C., Bi, M., Melli, K., Bluestone, J. A. (2008). Spontaneous Development of a Pancreatic Exocrine Disease in CD28-Deficient NOD Mice. J. Immunol. 180: 7793-7803 [Abstract] [Full Text]  
• Hochwald, S. N., Hemming, A. W., Draganov, P., Vogel, S. B., Dixon, L. R., Grobmyer, S. R. (2008). Elevation of Serum IgG4 in Western Patients With Autoimmune Sclerosing Pancreatocholangitis: A Word of Caution. Ann. Surg. Oncol. 15: 1147-1154 [Abstract] [Full Text]  
• Kinder, B. W., Collard, H. R., Koth, L., Daikh, D. I., Wolters, P. J., Elicker, B., Jones, K. D., King, T. E. Jr. (2007). Idiopathic Nonspecific Interstitial Pneumonia: Lung Manifestation of Undifferentiated Connective Tissue Disease?. Am. J. Respir. Crit. Care Med. 176: 691-697 [Abstract] [Full Text]  
• Chang, M.-C., Chang, Y.-T., Tien, Y.-W., Liang, P.-C., Jan, I-S., Wei, S.-C., Wong, J.-M. (2007). T-Cell Regulatory Gene CTLA-4 Polymorphism/Haplotype Association with Autoimmune Pancreatitis. Clin. Chem. 53: 1700-1705 [Abstract] [Full Text]  
• Ralli, S., Lin, J., Farrell, J., Leclercq, P., Meurisse, N., Honore, P., Raina, A., Yadav, D., Krasinskas, A. M., Brugge, W. R. (2007). Autoimmune pancreatitis.. NEJM 356: 1586-1587 [Full Text]